epclusa tablets film-coated
gilead sciences ireland uc - sofosbuvir, velpatasvir - tablets film-coated - 400mg+ 100mg
grateziano 400 mg film coated tablet
pharmaniaga logistics sdn. bhd. - sofosbuvir -
velsof tablets film-coated
m/s hetero labs ltd. - sofosbuvir, velpatasvir - tablets film-coated - 400mg+ 100mg
velpanat tablets film-coated
natco pharma limited-pharma division - sofosbuvir, velpatasvir - tablets film-coated - 400mg+ 100mg
epclusa 400mg100mg tablets
gilead sciences international ltd - sofosbuvir; velpatasvir - tablet - 400mg ; 100mg
harvoni (ledipasvir 90mgsofosbuvir 400mg) film-coated tablets
gilead sciences malaysia sdn. bhd. - sofosbuvir; ledipasvir -
buvir-lp film-coated tablet
ledispavir acetone solvate/ sofosbuvir - film-coated tablet - ledispavir acetone solvate 90mg, sofosbuvir 300mg - sofosbuvir and ledipasvir
sovaldi film-coated tablet
sofosbuvir - film-coated tablet - 400mg sofosbuvir - other antivirals for systemic use
sovaldi film-coated tablet
gilead sciences, inc. 333 lakeside drive, foster city, ca 94404, usa - sofosbuvir - film-coated tablet - 400mg sofosbuvir - other antivirals for systemic use
vosevi
gilead sciences (nz) - sofosbuvir 400mg; ; ; ; velpatasvir 100mg; ; ; ; voxilaprevir 100mg; - film coated tablet - active: sofosbuvir 400mg velpatasvir 100mg voxilaprevir 100mg excipient: colloidal silicon dioxide copovidone croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry beige 85f170040 - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults.